<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <bold class="bold">(1R,2S)-4-methyl-N-(1-(4-methylbenzyl)-2-phenylcyclopropyl)benzenesulfonamide (25).</bold> The product was obtained as a white powder in 50% yield. 
 <sup class="sup">1</sup>H NMR (400 MHz, CDCl
 <sub class="sub">3</sub>) δ 7.81 (d, 
 <italic class="italic">J</italic> = 8.3 Hz, 2H), 7.43 − 7.23 (m, 7H), 7.06 (d, 
 <italic class="italic">J</italic> = 7.9 Hz, 2H), 6.87 (d, 
 <italic class="italic">J</italic> = 7.9 Hz, 2H), 4.94 (s, 1H), 2.88 (d, 
 <italic class="italic">J</italic> = 14.6 Hz, 1H), 2.64 (dt, 
 <italic class="italic">J</italic> = 15.5, 7.8 Hz, 1H), 2.45 (s, 3H), 2.33 (s, 3H), 1.93 (s, 1H), 1.35 − 1.19 (m, 2H). 
 <sup class="sup">13 </sup>C NMR (101 MHz, CDCl
 <sub class="sub">3</sub>) δ 143.4, 139.6, 137.0, 136.1, 134.5, 129.7, 129.3, 129.2, 129.1, 128.3, 127.1, 126.7, 41.8, 38.2, 28.8, 21.5, 21.0, 17.8. HRMS (ESI): calculated for C
 <sub class="sub">25</sub>H
 <sub class="sub">25</sub>O
 <sub class="sub">2</sub>NS [M + H] 392.16788 found 414.15045 [M + Na].
</p>
